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Objectives: Recent studies of esophageal cancer (EC) and gastric cancer (GC) 
have been reported to have high incidence rates of these cancers in Golestan 
Province of Iran. The present study describes the geographical patterns of EC and 
GC incidence based on cancer registry data and display statistically signiﬁcant 
regions within this province. 
Methods: In order to map the distribution of upper gastrointestinal cancer, 
relative risk (RR) were calculated. Therefore, to estimate a more reliable RR, 
Poisson regression models were used. The adjusted models (adjusted to urban 
erural area, sex, and grouped age proportion) were utilized. We considered two-
component random effects for each observation, an unstructured (non­
correlated) and a group of “neighbor” (correlated) heterogeneities. We esti­
mated the model parameters using Gibbs sampling and empirical Bayes method. 
We used EC and GC data that were registered with Golestan Research Center of 
Gastroenterology and Hepatology in the years 2004e2008. 
Results: The EC and GC maps were drawn for 2004e2008 in the province. Kalaleh 
and Minoodasht counties have a high RR of EC and GC in the years of study. In 
almost all years, the areas with a high RR were steady. 
Conclusion: The EC and GC maps showed signiﬁcant spatial patterns of risk in 
Golestan province of Iran. Further study is needed to multivariate clustering and 
mapping of cancers RRs with considering diet and socioeconomic factors. igi@umsha.ac.ir (A. Moghimbeigi).
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101 The Gastric and Esophageal Cancers Incidence Mapping 1. Introduction 
About 70,000 new cases of cancer were diagnosed in 
the Iranian population in 2008 [1]. Esophageal cancer 
(EC) is the second and the third most common malig­
nancy in Iranian men and women, respectively [2]. Also, 
gastric cancer (GC) is a major problem in the world and 
it is the second leading cause of cancer deaths [3]. The 
incidence rate of EC/GC is 6.25/8.89 and 5.83/15.21 for 
women and men, respectively (during the period 
2005e2006) [4]. The northeastern part of Iran is known 
as the high-risk regions of the EC and GC in both male 
and female sexes [5]. Golestan is one of the northern 
provinces of Iran. The age-standardized incidence rate 
(ASR) per 100,000 personeyears of EC in Gonbad (a 
county in Golestan, Iran) is > 100 and this city is one of 
the high risk areas in the world [2]. The estimations of 
ASR (per 100,000) of EC are 17.6 and 14.4 in Iran [6] 
and 43.3 and 36.3 in the province for men and women, 
respectively [2]. Preliminary research carried out by the 
Iran cancer institute has shown that EC accounts for 
about 9% of all cancers and 27% of digestive cancers, 
and its prevalence in men is about 1.7 times higher than 
in women [4]. Recent research has reported that ASR 
(per 100,000) of GC in Iran is about 26.1 in and 11.1 in 
women [6]. 
In recent years, several studies have been conducted 
to map the geographical spread of EC and GC incidence 
using adjusted age-speciﬁc standardized incidence ratio 
(SIR) in the southwest of the Caspian Sea from 2001 to 
2005 [7,8]. The previous studies have considered 
counties of northern provinces of Iran as clustered. Most 
counties of Golestan are in the high-risk incidence rate 
cluster [7,8]. However, the incidences of these cancers 
are not the same in all regions of the province, despite 
being in a high-risk cluster. The purpose of this study is 
to evaluate and adjust EC and GC for contextual risk 
factors from 2004 to 2008, then identify counties in 
Golestan province that have the highest observed count/ 
expected count of these cancers compared with other 
regions within this province. Comparison with the re­
sults of other studies over the years can also be valuable. 2. Materials and methods 
2.1. Study population 
The population this study was residents of Golestan 
province. The estimated midyear population between 
2004 and 2008 that are stratiﬁed by sex, age (� 69 years 
and > 69 years), and place of residence (urban or rural) 
was obtained from the statistical center of Iran. The 
occurrences of new cases of EC and GC during a period 
of 4 years (2004e2008) were established from Golestan 
Research Center of Gastroenterology and Hepatology. 
The cancers were registered with procedures that are 
widely established throughout the world by the International Agency for Research on Cancer, the In­
ternational Association of Cancer Registries, and the 
World Health Organization. 2.2. Statistical analysis 
In many studies, the response variable is the counts of 
rare events, such as the number of new cancer cases in 
the population during a speciﬁed time. In such cases it is 
assumed that the response variable has a Poisson dis­
tribution [9]. In this study, SIR, the ratio of observed 
new cases (yiÞ to the expected number of new cases (eiÞ 
was used as the response variable. 
bqiZSIRiZyi 
ei 
The SIR is a crude estimate of underlying regional-
speciﬁc relative risks (RR). Hence smoothed estimates 
of RR for disease mapping were calculated using 
empirical Bayes method. We suppose that yi, the num­
ber of disease observed in study i-th county, has a 
Poisson distribution [yiw Poisson ðqieiÞ, i  Z 1,.,N]. 
where qi is the RR and the expected number of cases in 
the i-th county calculates as: PN 
eiZni PNiZ1yi 
niiZ1
where ni is the population at risk in the i-th county. 
In the model for RR to account heterogeneity, we 
considered two-component random effects for each 
observation, an unstructured (noncorrelated heteroge­
neity) and a group of “neighbor” (correlated heteroge­
neity) random effects [10e12]. This model has been 
presented and extended for disease mapping and clus­
tering [13,14]. It is formulated as follows: 
log qiZa þ ui þ vi 
where a is the overall effect, ui is correlated heteroge­
neity, and vi is the uncorrelated heterogeneity. Whereas 
estimating RR in each region depends on the neigh­
borhood, we applied the clustering structure for the 
2spatial correlations. Where viwNð0; t Þ and accordingly n 
for ui, Besag and Newell [14] have proposed a condi­
tional autoregressive structure as:    
uijuj; isj; t2 wN ui; t2 u i
X1 
uiZP ujwij 
jwij j 
t2 
t2 i ZP u 
jwij 
 
1 if i; j counties are adjacent 
wijZ 0 otherwise 
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Table 1. The median (M), and 2.5 and 97.5 percentiles of covariates effects on log (relative risk) in the adjusted model. 
2004 2005 2006 2007 2008 
Variables 2.5% M 97.5% 2.5% M 97.5% 2.5% M 97.5% 2.5% M 97.5% 2.5% M 97.5% 
Area EC -0.960 -0.007 1.196 -0.614 0.284 2.327 -0.881 0.050 1.523 -0.995 -0.043 0.931 -0.709 0.139 1.085 
GC -0.893 0.006 0.914 -0.697 0.058 0.934 -0.907 -0.034 0.817 -0.795 0.030 1.066 -1.037 -0.079 0.747 
Sex EC -2.328 -0.038 2.183 -2.888 0.042 3.368 -2.302 -0.019 2.535 -2.323 -0.040 2.139 -2.391 0.004 2.201 
GC -2.203 -0.017 2.050 -2.092 0.001 2.124 -2.093 -0.014 2.091 -2.074 -0.011 2.197 -2.238 -0.033 2.032 
Age EC -1.980 -0.067 1.825 -2.702 -0.108 2.588 -2.117 -0.068 1.979 -1.704 -0.022 1.974 -2.228 -0.062 2.172 
GC -1.749 -0.010 1.718 -1.736 -0.020 1.706 -1.626 -0.003 1.747 -1.973 -0.052 1.635 -1.735 -0.015 1.732 
EC Z esophageal cancer; GC Z gastric cancer. 
 �
where, the tu and tv control variability of u and v. We
have used the empirical Bayes model for estimating the 
model parameters. Uninformative prior distributions for 
the parameters of the model were considered as: 
aw Nð0; 0:001Þ 
tuw gammað0:01; 0:01Þ 
tvw gammað0:01; 0:01Þ 
The RR adjusted for the effect of the residential area 
(rural Z 0; urban Z 1), sex (male Z 0; female Z 1), 
and grouped age (< 69 years Z 0; 69 years Z 1) as: 
log qiZb1 þ b2area½i] þ b3gender½i] þ b4age½i] þ ui þ vi Table 2. The median (M), and 2.5 percentile and 97.5 percenti
2004 2005 
County 2.5% M 97.5% 2.5% M 97.5% 2
Kalaleh EC 1.638 2.211 2.893 1.269 1.763 2.359 1
GC 0.883 1.247 1.751 0.830 1.143 1.582 0
Gonbad EC 0.917 1.216 1.577 1.000 1.313 1.704 0
GC 0.951 1.235 1.604 0.758 0.983 1.254 0
Minoodasht EC 0.933 1.354 1.915 0.934 1.362 1.930 1
GC 0.661 0.994 1.412 0.670 0.956 1.315 0
Aghghala EC 0.303 0.578 0.961 0.719 1.120 1.686 0
GC 0.409 0.733 1.115 0.713 1.014 1.423 0
BandarTurkaman EC 0.384 0.656 1.039 0.293 0.547 0.881 0
GC 0.455 0.751 1.101 0.587 0.878 1.206 0
Azadshahr EC 0.523 0.901 1.442 0.517 0.891 1.425 0
GC 0.680 1.045 1.556 0.535 0.857 1.213 0
Ramian EC 0.213 0.505 0.933 0.331 0.694 1.183 0
GC 0.521 0.888 1.333 0.480 0.809 1.166 0
Aliabad EC 0.416 0.694 1.073 0.399 0.700 1.074 0
GC 0.780 1.114 1.605 0.636 0.921 1.245 0
Gorgan EC 0.507 0.701 0.941 0.479 0.665 0.898 0
GC 0.606 0.812 1.054 0.842 1.065 1.331 0
Kordkooy EC 0.449 0.821 1.403 0.501 0.892 1.522 0
GC 0.555 0.919 1.424 0.732 1.066 1.592 0
Bandar Gaz EC 0.343 0.717 1.372 0.208 0.540 1.042 0
GC 0.674 1.114 1.916 0.618 0.984 1.524 0
EC Z esophageal cancer; GC Z gastric cancer. We used OpenBUGS version 3.1.2 (produced by 
Medical Research Council (MRC) and Imperial College, 
UK), the Bayesian analysis of complex statistical soft­
ware to estimate parameters of the model with the 
GibbseBayesian method. We considered two indepen­
dent Markov chains. To ensure the convergence of 
chains, after visual inspections, we used GelmaneRubin, 
Geweke, RafteryeLewis, and HeidelbergeWelch diag­
nostic tests via R using the coda package [12,15]. After a 
sufﬁcient (10,000) burn-in to remove the effects of the 
initials, the following 100,000 iterations were sampled 
from each of the two chains choosing lag Z 10 to avoid 
possible autocorrelation. We considered multivariate 
normal as a prior for b1; b2; b3, and  b4 parameters. The 
estimated RRs were subsequently mapped with the 
GeoBugs tool in the OpenBUGS version 3.1.2. le of relative risk in each ward. 
2006 2007 2008 
.5% M 97.5% 2.5% M 97.5% 2.5% M 97.5% 
.470 2.010 2.690 1.223 1.703 2.317 1.321 1.806 2.425 
.855 1.202 1.669 0.811 1.169 1.649 0.805 1.152 1.618 
.974 1.290 1.674 0.852 1.122 1.443 0.990 1.282 1.501 
.788 1.029 1.326 0.635 0.872 1.147 0.659 0.895 1.174 
.163 1.661 2.309 0.775 1.148 1.641 1.037 1.485 1.795 
.880 1.234 1.762 0.838 1.215 1.752 0.984 1.415 2.028 
.447 0.782 1.253 0.460 0.762 1.158 0.462 0.776 1.017 
.532 0.845 1.211 0.471 0.793 1.206 0.518 0.829 1.228 
.565 0.909 1.412 0.409 0.685 1.041 0.413 0.680 0.921 
.507 0.795 1.133 0.385 0.682 1.052 0.490 0.787 1.148 
.407 0.770 1.277 0.585 0.949 1.448 0.475 0.832 12.212 
.670 1.015 1.492 0.466 0.807 1.256 0.618 0.977 1.467 
.209 0.511 0.958 0.376 0.709 1.132 0.341 0.687 0.929 
.378 0.748 1.129 0.565 0.924 1.447 0.446 0.789 1.219 
.496 0.808 1.252 0.406 0.688 1.034 0.596 0.911 1.220 
.739 1.046 1.482 0.353 0.637 0.997 0.465 0.765 1.118 
.365 0.531 0.739 0.753 0.974 1.250 0.462 0.635 0.811 
.762 0.972 1.233 0.945 1.202 1.505 0.882 1.124 1.411 
.280 0.599 1.096 0.324 0.643 1.086 0.415 0.763 1.114 
.506 0.847 1.285 0.828 1.311 2.090 0.395 0.745 1.181 
.233 0.575 1.145 0.317 0.668 1.194 0.471 0.886 1.232 
.406 0.781 1.258 0.437 0.851 1.454 0.475 0.872 1.473 
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Figure 1. Geographic boundaries of wards in Golestan 
provinces. 
Figure 2. Spatial pattern, local clusters and smoothed relativ3. Results 
The total numbers of new cases of the EC and GC 
during the study period (2004e2008) were 1100 and 
1122, respectively. The mean (standard deviation) age 
of EC and GC cases were 64.96 (11.919) and 65.16 
(12.975), respectively. 56.6% of EC and 70.9% of GC 
cases were male and 32.7% of EC and 42.2% of GC 
cases were resident in urban areas. 
Adjustment models by area (urbanerural), sex, and 
age effects to log (RR) ﬁtted. Table 1 shows 2.5%, 
median and 97.5% of posterior distributions of model 
parameters in the years. This reveals that none of the 
covariates signiﬁcantly affects the (logarithm of) RR of 
EC and GC. e risk of esophageal cancer incidence during 2004e2008. 
104 A.-S. Hosseintabar Marzoni, et al Table 2 shows the median, and 2.5 percentile and 
97.5 percentile in the RR (observed counts/expected 
counts) of diseases. In Kalaleh, the RR of EC is higher 
than other counties, such that the 2.5 percentile of the 
RR is > 1 in every year. Figure 1 shows geographic 
boundaries of the province. As adjusted models show 
(Table 2) the covariates of study are not signiﬁcant and 
when we mapped RR of GC and EC separately for both 
genders, the results were similar. We decided to map RR 
separately in years. Figures 2 and 3 show geographical 
patterns of EC and GC in the province. In these ﬁgures Figure 3. Spatial pattern, local clusters and smoothed rela� �
�
the counties were clustered into four groups; counties 
with: RR < 0.6, 0.6 RR < 0.75, 0.75 RR < 0.90, 
0.9 RR < 1.3, and RR > 1.3. It is clearly shown that 
Kalaleh, Minoodasht, and Gonbad have a higher RR of 
EC and GC than other counties in almost all years. 
4. Discussion 
In this study, we have created separate maps of EC 
and GC disease in the counties of Golestan province 
during 2004e2008. For comparison of incidence rates in tive risk of gastric cancer incidence during 2004e2008. 
105 The Gastric and Esophageal Cancers Incidence Mapping the counties, we adjusted RR with sex (male, female), 
age (< 69 years, � 69 years) resident in the region (rural, 
urban) populations. Based on the results of modeling and 
mapping for RR of EC and GC, it has been observed, the 
RR is higher for some counties and it highlights the 
possible role of geographical and cultural differences. 
According to Figure 2, Kalaleh and Minoodasht (except 
in 2007) have experienced a higher risk of incidence of 
EC than expected. After these two counties, Gonbad has 
a high RR of EC. In the previous study in the Caspian 
region of Iran (Mazandaran and Golestan provinces) 
using data collected during 2001e2005, Kalaleh, Min­
oodasht, Azadshahr, and Gonbad have higher risk of 
incidence of EC (� 1.33 times the expected) in both 
sexes [7]. In a recent study, adjusted on a diet and so­
cioeconomic factors, it was found that all regions of 
Golestan province have high standardized incidence rates 
of EC/GC [8]. We found that Gonbad has the highest; 
and Kalaleh and Minoodasht have a high RR of GC in 
both genders. Also, almost in all years, the areas with a 
high RR have been steady. 
Our study investigated the geographical distributions 
of new GC/EC cases to determine the counties at a high 
risk of cancer incidence. Our results are somewhat 
similar to the previous studies that include this province 
or neighborhood provinces [7]. Mohebbi et al [8] have 
adjusted the RR of EC and GC to diet and socioeco­
nomic factors in the province and neighboring areas. 
Multivariate clustering and mapping of cancers RRs 
with considering diet and socioeconomic factors are 
interesting for future studies. Conﬂicts of interest 
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